Revolutionizing the care of Parkinson’s disease

Parkinson’s disease is a progressive neurological disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which controls movement, resulting in tremors, slowness of movement, rigidity, and impaired balance and coordination – the primary symptoms of the disease.

The gold standard for evaluating Parkinson’s disease symptoms has primarily relied on subjective assessments during in-clinic visits using rating scales like the Unified Parkinson’s Disease Rating Scale (UPDRS). This approach, however, has specific limitations, leading to often incomplete disease progression evaluation. Over the last decades, various methods have been developed to assess the patients' motor symptoms more accurately.

April marks Parkinson’s Awareness Month, a time dedicated to increasing awareness about and elevating the conversation around Parkinson's disease, a neurological disorder that progressively impairs movement and function, affecting millions worldwide.